arrow
W

Wendy W.J. de Leng

university medical centre utrecht
H指数:39
被引数:4,823

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery Protocol

曲美替尼用于NRAS突变肿瘤:药物重定位计划的结果

2026-06-010
PRE
BRAFV600E-Mutated Central Nervous System Tumors Benefit from Treatment with Dabrafenib plus Trametinib: Results from the Drug Rediscovery Protocol

BRAFV600E突变型中枢神经系统肿瘤患者从达拉非尼联合曲美替尼治疗中获益:药物再发现方案研究的结果

2026-03-110
PRE
Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients

III期结肠癌患者对辅助化疗耐药的癌症相关成纤维细胞特征和SMAD4突变

2026-01-310
OAAI
Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk

与最初诊断为非高危神经母细胞瘤且具有高危临床病程相关的分子特征

Cancers
IF4.4
2026-01-170
OAAI
Clinical implications of whole genome sequencing in metastatic colorectal cancer

全基因组测序在转移性结直肠癌中的临床意义

2025-11-070
PRE
Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol

奥拉帕利用于携带同源重组修复基因突变的肿瘤患者:来自药物再发现方案的结果

2025-10-160
OAAI
Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours

MAP2K1突变的原发性皮肤黑色素细胞肿瘤的临床结局和基因组特征

2025-04-010
PRE
Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnostics

通过一种新的分析方法对实体瘤进行全面的基因组分析,以进行临床诊断中的广泛分析

2025-01-310
OAAI
Diffuse, IDH-wildtype gliomas in adults with minimal histological change and isolated TERT promoter mutation: not simply CNS WHO grade 4

成人弥漫性,IDH野生型神经胶质瘤,具有最小的组织学变化和孤立的TERT启动子突变: 不仅仅是CNS WHO 4级

2024-07-290
OAAI
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy
2024-05-151
PRE
Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)
2024-05-012
OA
Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting
2024-01-291
OAAI
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort
2023-11-093
OAAI
Formalin-Fixed, Paraffin-Embedded-Targeted Locus Capture A Next-Generation Sequencing Technology for Accurate DNA-Based Gene Fusion Detection in Bone and Soft Tissue Tumors
2023-10-014
OAAI
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials
2023-07-1013
OA